Science Explorer Back to mapMap
Discussion
Researcher · Ark Therapeutic (United States) · United States

Blaise Bayer

Blaise Bayer publishes mostly in Oncology, Immunology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and Advanced Breast Cancer Therapies.

OpenAlex
World rank
#5,259,405
of 7,710,434 ranked researchers
Rank in United States
#1,345,054
of 1,627,098
Works
25
Citations
3
Citations per work
0.1
h-index
1
i10-index 0Top 99.6% in Oncology
Blaise Bayer

What does Blaise Bayer research?

Blaise Bayer's work is mostly in Medicine (57%), Immunology and Microbiology (16%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 14 works · 57.2% of their workMedicine: 14 works · 57.2% of their workOncology: 10 works · 38.6% of their workPulmonary and Respiratory Medicine: 4 works · 14.3% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 4.3% of their workLife Sciences: 7 works · 27.1% of their workImmunology and Microbiology: 4 works · 15.7% of their workImmunology: 4 works · 15.7% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.4% of their workBiotechnology: 2 works · 7.1% of their workMolecular Biology: 1 works · 4.3% of their workEverything else: 4 works · 15.7% of their workTHEIR WORKBlaise Bayer25works
Life Sciences27%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1457.2%
    1. Immunology and Microbiology415.7%
    2. Biochemistry, Genetics and Molecular Biology311.4%
  3. Everything else415.7%
  1. 1Oncology39% of their works
  2. 2Immunology16% of their works
  3. 3Pulmonary and Respiratory Medicine14% of their works
  4. 4Biotechnology7% of their works
  5. 5Radiology, Nuclear Medicine and Imaging4% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Blaise Bayer's research?

The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Breast Cancer, CDK4/6 Inhibitors, Dendritic Cells, Immunity, Immunotherapy and Cancer Stem Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Immune Checkpoint Blockade111 topic
  2. PD-1 and PD-L1111 topic
  3. Breast Cancer81 topic
  4. CDK4/6 Inhibitors81 topic
  5. Dendritic Cells81 topic
  6. Immunity81 topic
  7. Immunotherapy82 topics
  8. Cancer Stem Cells71 topic
  9. Tumor Metastasis71 topic
  10. Bacterial Therapy51 topic
  11. Tumor Targeting51 topic
  12. BRCA Mutation31 topic
  13. Glioblastoma31 topic
  14. PARP Inhibitors31 topic
  15. Temozolomide31 topic
  16. Cancer Genomics21 topic
  17. Mutational Signatures21 topic

Where does Blaise Bayer work?

Blaise Bayer's main affiliation in the publication record is Ark Therapeutic (United States), United States.

How many publications and citations does Blaise Bayer have?

OpenAlex counts 25 works and 3 citations for Blaise Bayer, an h-index of 1, ranking #5,259,405 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Blaise Bayer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.